BIR/IDUG molecular radiotherapy dosimetry

29th September - 2nd October 2020   (GMT+01:00) Europe/London

This event is going virtual! 
Tuesday 29 September - Friday 2 October each day from 12:00-13:00 BST

You will need to sign-up with the BIR before registering. Please sign-up or login here.

Once logged in, click on the education tab and select education and events, you will then be able to register onto the event. 

Following three highly successful BIR/IDUG conferences in 2014, 2016 and 2018, this is an excellent opportunity to hear about the future of molecular radiotherapy dosimetry. Because of the ongoing uncertainty, this event will now be held virtually over four consecutive days during hour-long sessions from 12:00-13:00 BST. If you are unable to attend any of the live sessions, you will be able to access them on demand after the live sessions if you have registered for this event and still be able to get CPD for your participation. 


View the virtual event programme 

Registration fees*:
BIR members FREE
Non members £80

*VAT added at checkout

Thank you to our sponsors for their support on this virtual event
Please see below for special sponsor updates and videos

  • GE - Click here to see the newest product video 
  • Hermes- The importance of obtaining absolute, accurate and comparable values for the activity distribution within a patient for any radionuclide and camera manufacturer is described in the context of dosimetry in this educational talk: Hermes Medical Solutions SUV SPECT and Dosimetry. Hermes Medical Solutions SUV SPECT® provides the most consistent quantitative SPECT reconstruction on the market. Hermes Medical Solutions Voxel Dosimetry™ is also described, which calculates absorbed dose on a voxel basis using a Monte-Carlo approach that is personalized to the patient.
  • MIM- MIM Software invites you to set up a web meeting to discuss how MIM SurePlan™ MRT is making it easier for departments to implement recommendations for personalized dosimetry. Please click here to schedule a meeting.
Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees we advise them to fill out the event registration form and return to Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact
If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:

GE Healthcare Ltd

GE Healthcare is a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. Follow us on Facebook, LinkedIn, Twitter and Insights , or visit our website for more information.

Hermes Medical Solutions

Hermes Medical Solutions provides a comprehensive range of vendor-neutral software solutions for radionuclide therapy and dosimetry to help you personalise treatment for your patients, including Voxel Dosimetry with Monte Carlo dose simulation and theranostics dose prediction, organ dosimetry including OLINDA/EXM, and SUV-SPECT® quantitative SPECT reconstruction for any radionuclide and camera.

MIM Software Inc.

MIM Software offers a suite of applications that support Radiology and Nuclear Medicine’s important role in the patient care pathway. MIM products emphasize the importance of quantitation, collaboration, and data management. MIM SurePlan™ MRT provides voxel-based dosimetry for Molecular Radiotherapy, deformable registration, and timesaving tools for organ and tumor segmentation.


Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centers in over 50 countries.

Terumo UK Ltd

Terumo Interventional Systems is working in partnership with Interventional Radiologists and Nuclear Medics within Interventional Oncology to ensure they have access to high quality tools for their patients. QuiremSpheres®microspheres, QuiremScout® microspheres and Q-SuiteTM software make up The Holmium Platform: three integrated products which aims to individualize SIRT at its full potential.l QuiremSpheres® is the first Holmium-166 microsphere on the market which brings a wide range of benefits from higher dose rate, to optimized imaging capabilities.